Targinact 20 Mg 10 Mg Prolonged-release Tablets Summary Of Product Traits Smpc Emc
Targinact 20 Mg 10 Mg Prolonged-release Tablets Summary Of Product Traits Smpc Emc Second line symptomatic therapy of patients with severe to very extreme idiopathic restless legs syndrome after failure of dopaminergic therapy. Carcinogenicity was evaluated in a 2-year oral gavage study carried out in Sprague-Dawley rats. Oxycodone did not enhance the incidence of tumours […]
